Related Experiment Video
Updated: Jul 19, 2026
10:16
Production and Targeting of Monovalent Quantum Dots
Published on: October 23, 2014
26.0K
Recent Advancements in Graphene Quantum Dot-Based Bioimaging and Drug Delivery Systems.
Sachin Kadian1, Shubhangi Shukla1, Amit K Yadav2
1Joint Department of Biomedical Engineering University of North Carolina and North Carolina State University Raleigh North Carolina USA.
Medcomm
|September 26, 2025
Summary
Graphene quantum dots (GQDs) offer reduced toxicity and enhanced biocompatibility for biomedical uses. This review covers their synthesis, modifications, and applications in bioimaging and drug delivery.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Traditional quantum dots (QDs) have diverse optoelectronic applications.
- Graphene quantum dots (GQDs) exhibit low toxicity and good biocompatibility, suitable for biomedical fields.
Purpose of the Study:
- To review recent advances in graphene quantum dots (GQDs) for healthcare.
- Focus on GQD applications in bioimaging and drug delivery.
Main Methods:
- Overview of top-down and bottom-up GQD synthesis methods.
- Discussion of heteroatom incorporation (N, S, P) for property enhancement.
Main Results:
- GQDs show promise for advanced bioimaging and targeted drug delivery.
- Exploration of biological, optical, and toxicological properties of GQDs.
Conclusions:
- GQDs present significant potential for real-time bioimaging and drug delivery platforms.
- Challenges and future research directions for therapeutic agent release and medical diagnosis are outlined.
Keywords:
bioimagingbiomedical applicationsdrug deliverygraphene quantum dotsheteroatom dopingnanosized grapheneMore Related Videos
Related Concept Videos
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...